Core Insights - Tilray Medical has launched its cannabis brand Good Supply in Germany, aiming to provide affordable and reliable medical cannabis options for patients [1][2][3] - The introduction of Good Supply reflects Tilray's commitment to enhancing patient care and empowering healthcare professionals with innovative medical cannabis solutions [2][3] - Good Supply offers a variety of cannabis strains, available in both 15g and 500g, catering to the diverse needs of patients [2][7] Company Overview - Tilray Medical is a leading player in the global medical cannabis industry, with operations in Canada, Portugal, and Germany, and is recognized for its commitment to quality and innovation [3][4] - The company has established itself as a trusted supplier of medical cannabis, with a portfolio that includes multiple brands designed to meet patient needs worldwide [4][6] - Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company, focusing on cannabis, wellness, and entertainment, with a mission to inspire joy and create memorable experiences [6]

Group 1 - The Cronos Group is recognized as a pioneer in the cannabis industry, known for its strong brands and strategic investment partnerships [1] - The company is experiencing continuous revenue growth and has established itself as a significant player in the market [1] - The investment approach focuses on identifying undervalued businesses with strong fundamentals, aiming to build and preserve generational wealth [1] Group 2 - The investment strategy involves screening approximately 10,000 publicly listed companies to find dominant players in resilient sectors [1] - The emphasis is on companies led by shareholder-aligned management teams that generate strong free cash flows [1]

Core Viewpoint - MediPharm Labs Corp. is addressing concerns regarding Regan McGee, a dissident shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to the MediPharm board at the upcoming shareholder meeting [1][2]. Group 1: Allegations Against Regan McGee - Allegations have been made against Mr. McGee regarding his business conduct, including claims of misusing company resources and setting his own compensation through a conflicted process [3][6]. - Former colleagues of Mr. McGee have accused him of misrepresenting the nature of Nobul Technologies Inc.'s business, claiming it was a technology innovator when it primarily operated as a traditional real estate brokerage [7][8]. - There are serious allegations that Mr. McGee and his associates misled investors about Nobul's financial health and used funds for personal enrichment rather than business expansion [12][14]. Group 2: Legal Proceedings - Multiple litigation cases involving Nobul Technologies Inc. and Mr. McGee have been cited, including claims of fraudulent misrepresentation and breach of fiduciary duty [26][30]. - The allegations in these cases include claims that Mr. McGee used Nobul as a façade to deceive investors, leading to significant financial losses for those who invested based on misleading information [13][14]. - The legal actions also highlight governance issues, with former directors expressing concerns about Mr. McGee's control over the company and the lack of transparency in operations [10][11]. Group 3: MediPharm's Position - MediPharm urges shareholders to support its nominees and resolutions by voting with the GREEN proxy, emphasizing the importance of governance and the qualifications of its board members [16][17]. - The company has communicated that shareholders should disregard any outreach from the dissident group and focus on the information provided by MediPharm [18].

Strategic transaction will deepen Blüm's indirect stake in Cookies and will further align its platform with one of the most recognized cannabis brands in the U.S.DOWNEY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, today announced the execution of a binding term sheet to acquire 100% of the membership interest in a holding company (the “Target”). The ...

Core Viewpoint - Verano Holdings Corp. is expanding its retail presence in Connecticut with the opening of Zen Leaf Enfield, increasing its total dispensary count to 157 nationwide, and actively engaging in community development projects [1][2][5]. Group 1: Company Expansion - Zen Leaf Enfield will officially open on May 23, 2025, marking the seventh retail location for Verano in Connecticut [1]. - The company now operates 157 dispensaries across the United States and has 15 cultivation and processing facilities with over 1.1 million square feet of cultivation capacity [5][9]. Group 2: Community Engagement - Verano is supporting the Thompsonville Fire Department by providing funds for a year's supply of Narcan to aid in combating the opioid crisis [3][5]. - The company is also involved in local charitable initiatives, including a food donation drive for Enfield Loaves and Fishes and Enfield Food Shelf [3][5]. Group 3: Grand Opening Activities - The Grand Opening celebration will feature various activities, including a ceremonial ribbon cutting with community leaders and local partners [6][7]. - Special promotions will be available during the opening weekend, including discounts on cannabis products and complimentary food from local vendors [6][8]. Group 4: Local Economic Development - Zen Leaf Enfield is strategically located near the Enfield Square Mall, which is undergoing a $250 million redevelopment into the Enfield Marketplace, aimed at boosting local economic growth [2][5]. - The company aims to contribute to the long-term success of the Enfield community by investing in local job opportunities [2].

Core Viewpoint - Investing in stocks during market volatility requires a balanced strategy that focuses on growth, dividends, and stability to appeal to long-term investors while managing overall risk Group 1: Dividend Stocks - Allocating $5,000 to a top dividend stock can provide valuable recurring income, which can enhance overall returns and support day-to-day financial needs without liquidating other investments [3][5] - Enbridge (ENB) is highlighted as a strong dividend stock, offering a yield of 6%, significantly higher than the S&P 500 average of 1.3%, resulting in $300 per year in dividends from a $5,000 investment [4][5] - Enbridge has a track record of increasing its dividend for 30 consecutive years, indicating strong financial performance and the likelihood of continued dividend growth in the future [6] Group 2: Growth Stocks - A significant investment of $4,000 is recommended for a growth stock, with Alphabet (GOOG) identified as a suitable option due to its strong assets in YouTube and Google Search, along with heavy investments in artificial intelligence [7][8] - Despite facing antitrust concerns and a 12% decline in stock price in 2025, Alphabet's valuation at 19 times trailing earnings and its generation of $75 billion in free cash flow over the past 12 months presents a compelling investment opportunity [9][10] Group 3: Riskier Investments - The remaining $1,000 can be allocated to a riskier stock with high upside potential, such as Green Thumb Industries (GTBIF), a cannabis company with significant future value potential [11] - Green Thumb operates in 14 states with over 100 retail stores, and potential nationwide marijuana legalization could greatly benefit the company by improving access to funding and market efficiency [12][13] - Although Green Thumb has lost more than half of its value in the past three years due to industry challenges and skepticism about legalization, it remains one of the safer cannabis investments, making it a candidate for a modest position in a diversified portfolio [13][14]

Core Insights - FLUENT Corp. has launched its whole flower brand KNACK in Florida, expanding from its successful debut in New York [1][2] - KNACK offers a curated selection of hybrid, indica, and sativa strains in a 3.5-gram format, now available at all 35 FLUENT dispensaries in Florida [1] - The launch signifies FLUENT's commitment to enhancing the quality of whole flower products through improved cultivation practices and consumer engagement [3][5] Company Overview - FLUENT Corp. is a national cannabis consumer packaged goods company focused on operational excellence in cultivation, production, distribution, and retail [7] - The company operates in multiple states, including Florida, New York, Pennsylvania, and Texas, with over 700 employees across 8 cultivation and manufacturing facilities and 42 retail locations [9] - FLUENT's product portfolio includes various brands such as MOODS, Knack, Wandr, Bag-O, and Hyer Kind [7] Product Development - The introduction of KNACK in Florida is part of FLUENT's strategy to raise the standard of whole flower products in the state [3] - Future plans for KNACK include the release of multipack pre-rolls and larger whole flower sizes in Florida, following their recent success in New York [6] - The brand emphasizes quality, authenticity, and transparency, aiming to cater to true cannabis connoisseurs [5][8]

Austin, Texas, May 20, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) Reports Record Q1 2025 Revenue and Announces Strategic Milestones in Retail Technology, AI, and Cannabis Expansion Austin, TX – May 20, 2025 – MedX Holdings, Inc. (OTC: MEDH), the parent company of Lazydaze + Coffeeshop and Dazed Inc., announced its unaudited financial results for the first quarter of 2025 along with key strategic developments that continue to position the company as a leader in cannabis re ...

LONG BEACH, Calif. and TORONTO, May 20, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., today announces the mailing of its management information circular and related materials to shareholders in connection with the upcoming annual and special meeting of shareholders, to be held on June 20, 2025 (the "Meeting"), where disin ...

Steve McLean Named Interim Chief Financial OfficerLAS VEGAS, May 20, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced that Dennis Logan, the Chief Financial Officer of the Company, submitted his resignation effective May 31, 2025. Mr. Logan will be leaving the Company to pursue other opportunities. Mr. Logan has served as the Chief Financial Officer of the Company since 20 ...